Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.06 (-6.98%)
Close on Nov 17, 2026Market cap $41.57MP/E –Yield –
Talphera operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Talphera's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.27M. For fiscal 2025 it was -$11.36M. The highest annual figure on record is -$487.00K in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.36M | – |
| FY2024 | Dec 31, 2024 | -$12.68M | – |
| FY2023 | Dec 31, 2023 | -$17.49M | – |
| FY2022 | Dec 31, 2022 | -$28.33M | – |
| FY2021 | Dec 31, 2021 | -$30.00M | – |
| FY2020 | Dec 31, 2020 | -$38.51M | – |
| FY2019 | Dec 31, 2019 | -$51.18M | – |
| FY2018 | Dec 31, 2018 | -$29.08M | – |
| FY2017 | Dec 31, 2017 | -$29.77M | – |
| FY2016 | Dec 31, 2016 | -$29.40M | – |
| FY2015 | Dec 31, 2015 | -$19.95M | – |
| FY2014 | Dec 31, 2014 | -$34.46M | – |
| FY2013 | Dec 31, 2013 | -$487.00K | – |
| FY2012 | Dec 31, 2012 | -$24.58M | – |
| FY2011 | Dec 31, 2011 | -$15.29M | – |
| FY2010 | Dec 31, 2010 | -$12.23M | – |
| FY2009 | Dec 31, 2009 | -$19.42M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.40M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.44M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.25M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.61M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.95M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.25M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.41M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.24M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.75M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.00M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.94M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.35M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.71M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.33M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.69M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.16M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.47M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.32M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.30M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.41M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.37M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.68M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.78M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.54M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.32M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.61M | – |
See a number that looks wrong?